Pathologic complete response after induction therapy and surgery is an independed long-term survival prognostic factor in locally advanced non-small cell lung cancer (2018) Schreiner W, Dudek W, Lettmaier S, Rieker R, Fietkau R, Sirbu H Conference contribution Inflammatory cells infiltrating HPV positive and negative head and neck squamous cell carcinoma (2018) Distel L, Farhoumand D, Haderlein M, Fietkau R Conference contribution Effect of the kinase-inhibitor Palbociclib on radio-therapeutic treatment in a 3D cell culture model (2018) Jost T, Hecht M, Fietkau R, Distel L Conference contribution Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use (2018) Cao J, Wiesweg M, Fuchs M, Stein A, Karthaus M, Lettmaier S, Kretzschmar A, et al. Conference contribution 12x6Gy-the Erlangen stereotactic radiotherapy treatment concept result in 95% local progression-free survival for bronchial carcinoma and 83% for pulmonary metastases after 3 years (2018) Lubgan D, Rutzner S, Lambrecht U, Fietkau R Conference contribution RECREATE: Treatment reality for mRCCpatients following first line Pazopanib therapy - a retrospective chart review (2018) Hegele A, Von Der Heyde E, Goebell P, Huebner A, Zengerling F, Klier J, Belz H, et al. Conference contribution Prospective evaluation of geriatric assessment tools as predictors of functional outcome in old patients undergoing major urologic tumor surgery (2018) Kahlmeyer A, Losensky W, Sikic D, Wach S, Ritt M, Goebell P, Keck B, Wullich B Conference contribution Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients (2018) Rot S, Kaune T, Greither T, Kotrba J, Bache M, Al-Nawas B, Vordermark D, et al. Conference contribution Analysis of androgen receptor mRNA expression in urothelial carcinoma of the bladder (2018) Sikic D, Wirtz R, Wach S, Dyrskjot L, Erben P, Bolenz C, Breyer J, et al. Conference contribution A multicenter comparison of PD-L1 protein and mRNA expression in urothelial bladder cancer by immunohistochemistry and RT-qPCR (Checkpoint-Typer(C)): A round robin test by the BRIDGE-Consortium Germany (2018) Eckstein M, Wirtz R, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, et al. Conference contribution